Table 1.
Clinical characteristics of patients
| Characteristics | Control (n = 40) | SAP (n = 60) | UAP (n = 60) | AMI (n = 60) |
|---|---|---|---|---|
| Age (years) | 62.6 ± 7.9 | 61.9 ± 9.9 | 60.6 ± 9.9 | 62.9 ± 10.3 |
| Sex (male/female) | 29/11 | 44/16 | 37/23 | 41/19 |
| Hypertension, n (%) | 22 (55) | 34 (58) | 38 (61.3) | 32 (61.2) |
| Diabetes, n (%) | 6 (15) | 20 (28) | 14 (38.7) | 20 (37.3) |
| Smoking, n (%) | 14 (35) | 26 (40) | 23 (48) | 28 (35.8) |
| BMI (Kg/m2) | 23. 2 ± 3.9 | 24.8 ± 3.0* | 25.8 ± 2.7* | 25.9 ± 2.6* |
| TC (mmol/L) | 4.52 ± 0.99 | 4.09 ± 0.95 | 4.53 ± 1.19 | 4.40 ± 0.86 |
| TG (mmol/L) | 1.68 ± 1.75 | 1.84 ± 1.04 | 1.94 ± 1.61 | 1.82 ± 1.42 |
| LDL-C (mmol/L) | 2.71 ± 0.87 | 2.38 ± 0.81 | 2.69 ± 1.16 | 2.71 ± 0.78 |
| HDL-C (mmol/L) | 1.20 ± 0.34 | 1.11 ± 0.41 | 1.09 ± 0.37 | 0.94 ± 0.26* |
| GLU (mmol/L) | 5.07 ± 0.9 | 5.67 ± 2.03 | 6.22 ± 2.67 | 6.78 ± 2.91* |
| Creatinine (μmol/L) | 76.28 ± 14.97 | 88.24 ± 23.03* | 82.51 ± 20.29* | 87.77 ± 35.23* |
| CRP (mg/L) | 1.49 ± 0.99 | 2.61 ± 4.04 | 4.14 ± 4.09* | 7.53 ± 7.08* |
| LVEF (%) | 65.7 ± 5.0 | 62.6 ± 8.5 | 56.9 ± 12.5* | 48.5 ± 10.4* |
| LVEDD (mm) | 46.7 ± 3.2 | 48.1 ± 3.7 | 51.5 ± 7.6* | 52.7 ± 5.5* |
| Gensini score | 0 | 44.0 ± 30.2* | 52.0 ± 28.4* | 61.9 ± 34.5* |
| Medications, n (%) | ||||
| Aspirin | 6 (15) | 24 (40) | 23 (38.3) | 25 (41.7) |
| β-blocker | 6 (15) | 22 (36.7) | 26 (43.3) | 30 (50) |
| ACEI/ARB | 10 (25) | 22 (36.7) | 26 (43.3) | 21 (35) |
| CCB | 16 (40) | 32 (53.3) | 28 (46.7) | 26 (43.3) |
| Statin | 9 (22.5) | 22 (52) | 21 (35) | 20 (33.3) |
| Nitrate | 9 (22.5) | 9 (15) | 16 (26.7) | 17 (28.3) |
The data are given as the mean ± SD or number of patients. SAP: stable angina pectoris; UAP: unstable angina pectoris; AMI: acute myocardial infarction; TC: total cholesterol; TG: total triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; GLU: fasting glucose; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic dimension; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: Calcium channel blocker.
*P < 0.05 vs. control.